Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 8, 2020.
Article Versions
- Earlier version (February 4, 2020 - 09:06).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2020 by the American Society of Nephrology
Author Information
- Emmanuelle Plaisier, and
- Pierre Ronco
- Department of Nephrology Day Hospital, Tenon Hospital Assistance Publique des Hôpitaux de Paris, Paris, France
- Research Unit UMRS 1155, National Institute of Heath and Medical Research-INSERM, Paris, France
- Sorbonne Université, Paris 06, Paris, France
- Reference Center of Rare disease- idiopathic Nephrotic Syndrome, Paris, France
- European Rare Kidney Disease Reference Network-ERKNet, Heidelberg, Germany
- Correspondence:
Prof. Pierre Ronco, Department of Nephrology, Tenon Hospital, 4 rue de la Chine, 75020 Paris, France. Email: pierreronco{at}yahoo.fr
Statistics from Altmetric.com
Article usage
In this issue
Screening for Cancer in Patients with Glomerular Diseases
Jump to section
- Article
- Patient-Related Risk Factors for Cancer-Associated Glomerulopathy
- Effect of Histopathological Diagnosis of Glomerular Disease on Decision to Screen for Malignancy
- Malignancy-Associated Membranous Nephropathy
- Proposed Cancer Screening of Patients with Nephrotic Syndrome
- Disclosures
- Funding
- Acknowledgments
- Footnotes
- References
- Figures & Data Supps
- Info & Metrics
- View PDF
More in this TOC Section
Cited By...
- No citing articles found.
Similar Articles
Related Articles
Keywords
- cancer
- nephrotic syndrome
- membranous nephropathy
- Humans
- human PLA2R1 protein
- phospholipase A2 receptors
- membranoproliferative glomerulonephritis
- nephrologists
- Immunosuppressive Agents
- risk factors
- nephrology
- cost-benefit analysis
- early detection of cancer
- Follow-Up Studies
- kidney
- Recurrence
- phospholipases A2
- cytosolic phospholipases A2
- treatment failure
- thrombospondins
- Neoplasms